Fosfomycin Disodium Powder, a potent broad-spectrum antibiotic, effectively inhibits bacterial cell wall synthesis against both Gram-positive and Gram-negative bacteria. It is a trusted option for healthcare providers treating urinary tract infections caused by multidrug-resistant organisms, given its efficacy and safety profile.
Laboratories rely on Fosfomycin Disodium Powder for susceptibility testing, a crucial step in selecting the most appropriate treatment strategies based on bacterial susceptibility patterns. This antibiotic’s ability to aid in identifying the most effective antibiotics for individual infections is invaluable in guiding patient care.
In summary, Fosfomycin Disodium Powder’s broad-spectrum activity, particularly against challenging multidrug-resistant bacteria, its efficacy in treating urinary tract infections, and its pivotal role in susceptibility testing are indispensable in modern medical practice. Its importance extends to clinical treatment decisions, microbiological labs, and the ongoing battle against antibiotic resistance.
| Cat. Number | AS-2032 |
| CAS Number | 26016-99-9 |
| Additional CAS | 23155-02-4 (base) |
| MDL Number | MFCD22741288 |
| Pubchem | 310278942 |
| Molecular Weight | 182.02 gr/mol |
| Molecular Formula | C3H5Na2O4P |
| Storage Temperature | +4°C |
| Form and Color | Powder / White to almost white |
| Assay (anhydrous) | 95 – 101 % |
| Solubility | 5 g in 50 ml water |
| pH (1 g in 20 ml water) | 9 – 10.5 |
| Specific Optical Rotation (2.5 gr in 50 ml water) | -13 - -15 ° |
| Heavy Metals | ≤ 20 ppm |
| Water | ≤ 1% |
| Synonym | Disodium (1R,2S)-(1,2-epoxypropyl)phosphonate |
